HOUR LOOP INC (HOUR)

US44170P1066 - Common Stock

1  -0.18 (-15.25%)

Fundamental Rating

2

HOUR gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 33 industry peers in the Broadline Retail industry. HOUR has a bad profitability rating. Also its financial health evaluation is rather negative. HOUR has a valuation in line with the averages, but it does not seem to be growing.



1

1. Profitability

1.1 Basic Checks

In the past year HOUR has reported negative net income.
In the past year HOUR has reported a negative cash flow from operations.
In multiple years HOUR reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: HOUR reported negative operating cash flow in multiple years.

1.2 Ratios

The Return On Assets of HOUR (-12.48%) is worse than 78.79% of its industry peers.
HOUR has a worse Return On Equity (-54.80%) than 75.76% of its industry peers.
Industry RankSector Rank
ROA -12.48%
ROE -54.8%
ROIC N/A
ROA(3y)2.41%
ROA(5y)7.44%
ROE(3y)34.71%
ROE(5y)15.86%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

HOUR has a Gross Margin of 50.35%. This is in the better half of the industry: HOUR outperforms 69.70% of its industry peers.
HOUR's Gross Margin has declined in the last couple of years.
HOUR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 50.35%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.25%
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

HOUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for HOUR remains at a similar level compared to 1 year ago.
Compared to 1 year ago, HOUR has a worse debt to assets ratio.

2.2 Solvency

HOUR has an Altman-Z score of 8.24. This indicates that HOUR is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 8.24, HOUR belongs to the best of the industry, outperforming 90.91% of the companies in the same industry.
HOUR has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of HOUR (0.15) is better than 60.61% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Altman-Z 8.24
ROIC/WACCN/A
WACC10.96%

2.3 Liquidity

A Current Ratio of 1.65 indicates that HOUR should not have too much problems paying its short term obligations.
HOUR has a Current ratio of 1.65. This is comparable to the rest of the industry: HOUR outperforms 54.55% of its industry peers.
HOUR has a Quick Ratio of 1.65. This is a bad value and indicates that HOUR is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.34, HOUR is doing worse than 90.91% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.65
Quick Ratio 0.34

3

3. Growth

3.1 Past

The earnings per share for HOUR have decreased strongly by -43.38% in the last year.
The Revenue has grown by 37.73% in the past year. This is a very strong growth!
HOUR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 50.63% yearly.
EPS 1Y (TTM)-43.38%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q41.55%
Revenue 1Y (TTM)37.73%
Revenue growth 3Y50.63%
Revenue growth 5YN/A
Revenue growth Q2Q16.14%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y160%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year25.04%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

4

4. Valuation

4.1 Price/Earnings Ratio

HOUR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 7.54 indicates a rather cheap valuation of HOUR.
84.85% of the companies in the same industry are more expensive than HOUR, based on the Price/Forward Earnings ratio.
HOUR is valuated cheaply when we compare the Price/Forward Earnings ratio to 20.41, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 7.54

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

HOUR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for HOUR!.
Industry RankSector Rank
Dividend Yield N/A

HOUR LOOP INC

NASDAQ:HOUR (5/6/2024, 8:34:41 AM)

1

-0.18 (-15.25%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap35.10M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 7.54
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.48%
ROE -54.8%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 50.35%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover6.76
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.65
Quick Ratio 0.34
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-43.38%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y160%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)37.73%
Revenue growth 3Y50.63%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y